|
BCCIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.248400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.51910000000855E-05 |
| Normal-vs-Stage2 |
2.364200E-03 |
| Normal-vs-Stage3 |
8.962500E-03 |
| Normal-vs-Stage4 |
9.541400E-01 |
| Stage1-vs-Stage2 |
8.868400E-01 |
| Stage1-vs-Stage3 |
4.208400E-01 |
| Stage1-vs-Stage4 |
1.410410E-02 |
| Stage2-vs-Stage3 |
6.248200E-01 |
| Stage2-vs-Stage4 |
2.491900E-02 |
| Stage3-vs-Stage4 |
7.186000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.039600E-04 |
| Normal-vs-AfricanAmerican |
4.939800E-03 |
| Normal-vs-Asian |
1.872020E-01 |
| Caucasian-vs-AfricanAmerican |
3.801000E-01 |
| Caucasian-vs-Asian |
6.321400E-01 |
| AfricanAmerican-vs-Asian |
8.590000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.79129999955796E-07 |
| Normal-vs-Female |
1.088170E-01 |
| Male-vs-Female |
1.458960E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.574100E-04 |
| Normal-vs-Extreme_Weight |
4.589900E-04 |
| Normal-vs-Obese |
4.204700E-03 |
| Normal-vs-Extreme_Obese |
6.236700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.115600E-01 |
| Normal_Weight-vs-Obese |
5.151000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.403400E-01 |
| Extreme_Weight-vs-Obese |
5.288000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.935000E-01 |
| Obese-vs-Extreme_Obese |
5.680600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.825000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.162500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.43669999996821E-06 |
| Normal-vs-Age(81-100Yrs) |
1.5583299999955E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.255800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.299900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.423800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.864100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.736090E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.893180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.190000E-04 |
| Normal-VS-Type2 PRCC |
1.33680000002911E-06 |
| Normal-VS-KIRP CIMP |
3.192200E-01 |
| Normal-VS-Unclassified PRCC |
4.216100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.452200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.755100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.618600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.037590E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.114800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.815750E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.155550E-04 |
| Normal-vs-N1 |
3.998200E-01 |
| Normal-vs-N2 |
2.138200E-01 |
| N0-vs-N1 |
1.493730E-02 |
| N0-vs-N2 |
6.487800E-01 |
| N1-vs-N2 |
5.301400E-01 |
|
|
